Abstract:Objective:To explore the genetic mutation, clinical characteristics, diagnosis and treatment of patients with hereditary coagulation factor FⅪ deficiency.Methods:On August 10 and October 30, 2020, two patients with hereditary FⅪ deficiency who were admitted at Department of Hematology, West China Hospital of Sichuan University were selected as research subjects. Patients 1 and 2 were numbered according to visiting time. Diagnosis was made according to coagulation function test and results of gene sequencing F11 gene.Clinical observation or symptomatic treatment were performed according to clinical bleeding symptom and severity. Novel mutations were confirmed by retrieving Human Gene Mutation database (HGMD), Single Nucleotide Polymorphism Database (dbSNP) and PubMed database. Pathogenicity of the novel missense mutation was predicted by computational software of Mutation Taster, Polyphen-2, and PROVEAN. Follow-up of patients was conducted until February 28, 2021. Clinical manifestations and process of diagnosis and treatment of two patients were analyzed retrospectively. China National Knowledge Infrastructure database, Wanfang Data Knowledge Service Platform, PubMed database were searched for the same and similar case reports as F11 genetic mutation in this study.Retrieval time was from database inception to February 28, 2021. Types of genetic mutations and clinical manifestations related to patients in this study were summarized.This study meeted the requirements of the World Medical Association Declaration of Helsinki revised in 2013. Informed consent of patients was obtained from pateints. Results:① Results of medical history: patient 1, a 24 years old man, was admitted due to " hematoma after soft tissue trauma in left thigh and preoperative examination revealed coagulation dysfunction" and did not complain of significant discomfort.Patient 2, a 32 years old woman, was admitted due to " pre-pregnancy physical examination found prolonged activated partial thromboplastin time (APTT)" and complained of occasional ecchymosis.② Results of related laboratory examination: APTT, prothrombin time (PT) and FⅪ activity (FⅪ∶C) of patient 1 were 97.9 s, 11.9 s and 0.6%, while patient 2 were 95.4 s, 12.5 s, and 1.2%, respectively. ③ Results of DNA sequencing: patient 1 had a compound heterozygous missense mutation of F11 gene at c. 149G>T(p.Cys50Phe) and c. 1204C>T (p.Gln402Ter), while patient 2 had a homozygous deletion of F11 gene at c. 1058delA (p.Asn353ThrfsTer18). ④ F11 gene missense mutation at c. 149G>T(p.Cys50Phe) and deletion c. 1058delA(p.Asn353ThrfsTer18) were two novel mutations and both were pathogenic.⑤Results of treatment and follow-up: two patients received clinical observation. At end of follow-up, general condition of the patients was good. ⑥ Results of literatures review: among 10 patients reported in 6 relevant literatures, there were 1, 3, 6 patients caused by heterozygous nonsense mutation of c. 1204C>T(p.Gln402Ter), nonsense mutation of c. 1202C>T(p.Trp401Ter) adjacent to c. 1204C>T (p.Gln402Ter) and missense mutations near the position of c. 149G>T(p.Cys50Phe), respectively. Conclusions:Two novel mutations of hereditary FⅪ deficiency namely a missense mutation at c. 149G>T(p.Cys50Phe) and a deletion at c. 1058delA(p.Asn353ThrfsTer18) of F11 gene were reported in this study. Both of the two mutations related to decrease of FⅪ∶C.

Detection of Factor Ⅸ gene Mutation in Paitients with Hemophilia B by DNA Sequencing

[Detection of Factor IX Gene Mutation in Patients with Hemophilia B by DNA Sequencing].

[Gene diagnosis of 3 haemophilia B families].

Identification of Mutations in the F8 and F9 Gene in Families with Haemophilia Using Targeted High-Throughput Sequencing.

Genetic analysis of patients with hereditary coagulation factor Ⅺ deficiency and literatures review

Gene Analysis and Pathogenesis in 40 Patients with Hemophilia B

A Genetic Analysis of 23 Chinese Patients with Hemophilia B

Study on the Mutation of FⅨ Gene in 31 Patients with Type B Hemophilia

A Strategy for the Molecular Diagnosis in Hemophilia A in Chinese Population

Detection by Denaturing Gradient Gel Electrophoresis of an Arg1689Cys Mutation in a Chinese Patient with Mild Hemophilia A.

Frameshift mutations in poly A stretches of exon 14 in the factor Ⅷ gene and its possible mechanism

[Clinical and Genetic Analyses of Hereditary Factor Ⅴ Deficiency Cases].

Identification of Gene Mutations in Two Coagulation Factor V Deficiency Patients

The Application of High-Resolution Melting Curve Analysis in the Detection of F9 Gene Mutations in Haemophilia B Patients

[Mutation screening of the F VIII gene in 10 hemophilia A families].

Development and Application of Molecular Diagnostic Method of Hemophilia A

Characterization of Genetic Defects in Casese of Haemophilia A of Chinese Origin

Molecular Diagnosis of Haemophilia B Leyden In a Chinese Pedigree: C>G Transition At Position +9 of the FIX Gene

Direct Sequencing in Hemophilia A Carrier Diagnosis and Prenatal Diagnosis

[Application Studies on the Gene Diagnosis and Carrier Detection of Hemophilia A by Using Polymerase Chain Reaction-Conformation Sensitive Gel Electrophoresis].

Molecular analysis of the discrepancy between the genotypes and phenotypes in a inherited coagulation factor Ⅶ deficiency.